8-K: Abpro Holdings Faces Nasdaq Delisting Threat Due to Low Stock Price

Abpro Holdings, Inc. received a notice from Nasdaq for failing to meet the minimum bid price requirement for continued listing.

Summary

• Abpro Holdings, Inc. received a notice from Nasdaq on April 2, 2025, stating that it no longer complies with the minimum bid price requirement of $1.00 per share for continued listing.
• The company has an initial compliance period of 180 calendar days, until September 29, 2025, to regain compliance.
• To regain compliance, the closing bid price of Abpro's common stock must be at least $1.00 per share for a minimum of 10 consecutive business days.
• If compliance is not achieved by September 29, 2025, the company may be eligible for an additional 180-day compliance period.
• Failure to regain compliance within the given periods may result in delisting of the company's common stock from Nasdaq.
• Abpro intends to monitor its stock price and consider available options to address the noncompliance.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the delisting notice from Nasdaq, indicating financial distress and potential challenges for the company.

Negatives

• Abpro Holdings is at risk of being delisted from the Nasdaq Stock Market due to its failure to maintain a minimum bid price of $1.00 per share.

Risks

• The primary risk is the potential delisting from Nasdaq, which could negatively impact investor confidence and the company's ability to raise capital.
• The company's stock price may remain depressed, making it difficult to regain compliance within the given timeframe.

Future Outlook

The company intends to monitor the closing bid price of its common stock and consider its available options to resolve the noncompliance with the Minimum Bid Price Requirement.

Management Comments

• Miles Suk, Chief Executive Officer, signed the report on behalf of Abpro Holdings, Inc.

Industry Context

Many small-cap biotech companies face challenges in maintaining their stock price above the Nasdaq minimum bid price, especially during periods of market volatility or negative clinical trial results.

Stakeholder Impact

• Shareholders may experience a decline in the value of their investment if the company is delisted.
• Employees may face uncertainty regarding their job security if the company's financial situation worsens.

Next Steps

• Abpro Holdings will monitor its stock price.
• Abpro Holdings will consider available options to resolve the noncompliance with the Minimum Bid Price Requirement.

Key Dates

Keywords

delisting, Nasdaq, minimum bid price, compliance, stock price, Abpro Holdings